Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers

por Fuchs, Hendrik, Weng, Alexander, Gilabert-Oriol, Roger
Publicado 2016

Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia

por Chen, Kent T. J., Gilabert-Oriol, Roger, Bally, Marcel B., Leung, Ada W. Y.
Publicado 2019

Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy

por Gilabert-Oriol, Roger, Weng, Alexander, von Mallinckrodt, Benedicta, Melzig, Matthias F, Fuchs, Hendrik, Thakur, Mayank
Publicado 2014

Optimization of liposomal topotecan for use in treating neuroblastoma

por Chernov, Lina, Deyell, Rebecca J., Anantha, Malathi, Dos Santos, Nancy, Gilabert‐Oriol, Roger, Bally, Marcel B.
Publicado 2017

Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response

por Gilabert-Oriol, Roger, Ryan, Gemma M., Leung, Ada W.Y., Firmino, Natalie S., Bennewith, Kevin L., Bally, Marcel B.
Publicado 2018

An unusual type I ribosome-inactivating protein from Agrostemma githago L.

por Weise, Christoph, Schrot, Achim, Wuerger, Leonie T. D., Adolf, Jacob, Gilabert-Oriol, Roger, Sama, Simko, Melzig, Matthias F., Weng, Alexander
Publicado 2020

Reporter Assay for Endo/Lysosomal Escape of Toxin-Based Therapeutics

por Gilabert-Oriol, Roger, Thakur, Mayank, von Mallinckrodt, Benedicta, Bhargava, Cheenu, Wiesner, Burkhard, Eichhorst, Jenny, Melzig, Matthias F., Fuchs, Hendrik, Weng, Alexander
Publicado 2014